Identifying research priorities for severe paranoia
25 July 2025
We talk to lead author David Sher about his paper, which aimed to establish potential research priorities for understanding and treating severe paranoia for the first time.
'I always say that inclusion without influence is tokenism' - Chris Frederick at the Race and Psychiatry Journal Club
22 July 2025
DPhil student Maya Ogonah, co-founder of the Race and Psychiatry journal Club in the Department of Psychiatry, interviews Chris Frederick, a mental health lived experience advisor and suicide attempt survivor.
Key outputs from Attune project on adverse childhood experiences and mental health
17 July 2025
The ATTUNE project, focused on understanding adolescent mental health and childhood adversities through the use of participatory arts methods, is due to conclude at the end of August 2025.
Certain chronic health conditions associated with increased risk of dementia – new study
17 July 2025
Developing cardiovascular, mental health and neurological-related illnesses before the age of 70 is associated with a greater risk of dementia later in life, with the more of these conditions accumulated the greater the risk, according to a new study by the University of Oxford.
Incorporating physical health considerations into mental health strategies could save millions of pounds
10 July 2025
Reducing the number of physical health issues associated with mental health conditions by just 1% could translate to savings of over €190 million (equivalent to around £164 million) in hospital costs every year in Europe.
Antidepressant withdrawal symptoms not generally that common, major new study finds
10 July 2025
The largest review of antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most people do not experience severe withdrawal.
Award in memory of Dr Valeria Frighi given to psychology trainee Michael Barry
1 July 2025
The £1,000 fund was set up to support researchers with an interest in intellectual disabilities.
Parkinson’s drug effective in treating persistent depression
30 June 2025
A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford.
How do vaccines reduce the risk of dementia?
25 June 2025
Chemicals (‘adjuvants’) contained in some vaccines may be one reason, according to new study by a team at the Department of Psychiatry, University of Oxford.
Oxford-developed support for child anxiety to be adapted for families in Chile
24 June 2025
The successful parent-led programme, developed with support from the NIHR ARC OxTV, is being culturally adapted in a new international collaboration.
New OPM-MEG brain scanner installed at the Oxford Centre for Human Brain Activity (OHBA)
19 June 2025
The advanced technology will open new avenues for research, including scanning children, dementia patients and enable full-body movement studies.
Oxford strengthens global mindfulness research with £1 million gift
12 June 2025
The University of Oxford has announced a £1 million donation to advance the work of the Oxford Mindfulness Research Centre.
Associate Professors appointed to the Department of Psychiatry
2 June 2025
Four Associate Professors have been appointed in the most recent Recognition of Distinction round.
From conversation to collaboration: Departments tackle shared health challenges
23 May 2025
Researchers from the Department of Psychiatry and Nuffield Department of Primary Health Care Sciences came together last week for a collaborative showcase, aiming to spark new ideas for collaborative research by identifying areas of shared interest and potential.
Professor Naomi Wray elected to the Academy of Medical Sciences Fellowship
22 May 2025
Fellowship of the Academy is based on exceptional contributions to the medical sciences.
Obesity drugs found to improve emotional wellbeing as well as physical health
16 May 2025
A major new meta-analysis has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) may also offer benefits for emotional wellbeing.
A landmark experiment puts leading theories of consciousness to the test
1 May 2025
Professor Ole Jensen part of a global consortium that embraced a novel collaborative approach to investigating one of the brain’s greatest mysteries.
New study launched investigating the day-to-day experience of patients with psychiatric disorders
29 April 2025
The collaboration between the University of Oxford's Department of Psychiatry, Boehringer Ingelheim and Cumulus Neuroscience is the first of its kind.
Novel insights and perspectives into diabetes and obesity medications (GLP-1RAs) to treat dementia
16 April 2025
Researchers have conducted an extensive review of studies of GLP-1RAs like semaglutide, better known as Ozempic or Wegovy.
'It makes one realise how much expertise we have within the country' - chairing an Ethics Committee
8 April 2025
Postdoctoral Researcher Isabelle Butcher talks to us about her experience in chairing a Health Research Authority Ethics Committee.